Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Challenges and adherence to hepatocellular carcinoma surveillance in patients with advanced chronic liver disease.

Annals of hepatology·2026
Same author

HCV RNA quantification using the Cobas Plasma Separation Card as an alternative to EDTA plasma: a prospective multicenter study.

Scientific reports·2026
Same author

Impact of cultivar on grapevine physiological adaptation to drought and subsequent rehydration.

Frontiers in plant science·2026
Same author

Change and Tracking of Physical Fitness Among Children Aged 5-12 Years: A Systematic Review.

Sports (Basel, Switzerland)·2026
Same author

The Impact of Polyethylene Glycol Lipid Anchors on the Physicochemical Properties, Protein Corona, Function, and Biodistribution of Lipid Nanoparticles.

ACS nano·2026
Same author

EXcellence and PERformance in Track and Field (EXPERT)-A Mixed-Longitudinal Study on Growth, Biological Maturation, Performance, and Health in Young Athletes: Baseline Results (Part 2).

Journal of functional morphology and kinesiology·2026

相关实验视频

Updated: Jun 28, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

16.9K

推进细胞特异性传递:机器学习对脂质纳米颗粒设计和细胞热带主义的洞察

Belal I Hanafy1, Michael J Munson2, Ramesh Soundararajan1

  • 1Advanced Drug Delivery, Pharmaceutical Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.

Advanced healthcare materials
|May 6, 2025
PubMed
概括

这项研究开发了一种数据驱动的方法,用于设计脂质纳米颗粒 (LNP) 以针对免疫细胞,克服肝脏特定的传递限制. 优化的LNP显示了免疫细胞吸收的增强和减少肝脏积累,扩大了LNP的治疗应用.

关键词:
细胞热带主义 细胞热带主义实验的设计实验的设计脂质纳米颗粒的使用方法提供mRNA的交付.机器学习是机器学习.蛋白质表达 蛋白质表达

更多相关视频

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

22.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.3K

相关实验视频

Last Updated: Jun 28, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

16.9K
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

22.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.3K

科学领域:

  • 生物技术是生物技术.
  • 纳米医学是一种纳米医学.
  • 药物输送系统 药物输送系统

背景情况:

  • 脂质纳米粒子 (LNP) 是先进的核酸输送系统,但它们的主要肝脏向限制了更广泛的治疗用途.
  • 开发具有特定免疫细胞热流的LNP对于扩大它们在治疗免疫相关疾病中的应用至关重要.

研究的目的:

  • 使用数据驱动的方法设计脂质纳米粒子 (LNPs) 以优先针对免疫细胞.
  • 为了确定LNP配方,增强免疫细胞的特异性和减少肝脏吸收.
  • 为了证明定制的LNP组合物对选择性细胞热带主义的潜力.

主要方法:

  • 一种数据驱动的方法,结合了实验设计 (DoE),高通量选 (HTS) 和机器学习 (ML).
  • 180种LNP配方的生成和体外查,具有不同的脂质成分.
  • 在体内验证针对免疫细胞向和生物分布的选定LNP.

主要成果:

  • 通过ML分析识别具有改善免疫细胞选择性概况的LNP配方.
  • 在体内证明精选的LNP的偏好性脏表达.
  • 成功地将LNP热从肝细胞转向免疫细胞.

结论:

  • 定制LNP成分对于实现选择性细胞热带性至关重要.
  • 实施的数据驱动工作流有效地识别了具有所需免疫细胞向能力的LNP.
  • 这一策略将LNP的治疗潜力扩大到针对肝脏的应用之外.